When sourcing high-purity reagents from an established follistatin peptid store, laboratory researchers require rigorous analytical validation, batch-level transparency, and verified structural integrity. Follistatin is an endogenous autocrine glycoprotein that functions as a high-affinity antagonist to transforming growth factor-beta (TGF-β) superfamily ligands, including myostatin (GDF-8) and activin A. PX1 Research provides researchers with validated, research-grade Follistatin compounds manufactured under strict quality standards exclusively for in vitro and preclinical experimentation.
When sourcing high-purity reagents from an established follistatin peptid store, laboratory researchers require rigorous analytical validation, batch-level transparency, and verified structural integrity. Follistatin is an endogenous autocrine glycoprotein that functions as a high-affinity antagonist to transforming growth factor-beta (TGF-β) superfamily ligands, including myostatin (GDF-8) and activin A. PX1 Research provides researchers with validated, research-grade Follistatin compounds manufactured under strict quality standards exclusively for in vitro and preclinical experimentation.
In the landscape of life science research, identifying a dependable follistatin peptid store is essential for obtaining consistent, reproducible experimental outcomes. Follistatin (FST) plays a pivotal regulatory role across cellular differentiation, tissue homeostasis, and folliculogenesis. Because minute impurities or sequence variations can significantly alter receptor binding kinetics, principal investigators and bench scientists depend on suppliers that adhere to uncompromising quality control protocols.
PX1 Research serves the global scientific community by providing research-grade peptides synthesized in domestic, GMP-compliant facilities. Every lot undergoes thorough analytical verification, including reverse-phase high-performance liquid chromatography (RP-HPLC) and electrospray ionization mass spectrometry (ESI-MS). By exploring our comprehensive follistatin research catalog, laboratories gain access to peptides characterized by precise molecular weights, high sequence purity, and low endotoxin levels suitable for delicate cell culture and preclinical models.
Follistatin exists in several distinct structural isoforms generated via alternative splicing and post-translational proteolysis. Understanding these biochemical distinctions is crucial when selecting candidates from a follistatin peptid store for specific experimental designs:
FST-288 is the precursor transcript containing 288 amino acids, characterized by a highly basic, heparin-binding C-terminal domain that anchored it firmly to cell surface glycosaminoglycans. FST-315 is the primary full-length circulating isoform comprising 315 amino acids, where the C-terminal sequence masks the heparin-binding site, allowing it to circulate systemic blood plasma without immediate tissue immobilization.
FST-344 is a precursor form containing a 29-amino-acid signal peptide that is naturally cleaved to yield active FST-315 or localized derivatives. In recombinant preclinical synthesis, formulations modeled on Follistatin-344 are frequently investigated for localized transfection and overexpression models due to their predictable processing and signaling activity.
The primary biochemical function of Follistatin involves bivalent binding to specific members of the TGF-β ligand family. Preclinical studies suggest that Follistatin forms an irreversible, high-affinity complex with Activin A and Myostatin (Growth Differentiation Factor 8, or GDF-8), preventing these ligands from engaging their cognate cell surface receptors, Activin Type IIA (ActRIIA) and Activin Type IIB (ActRIIB).
By occupying the receptor-binding epitopes of GDF-8, Follistatin suppresses downstream Smad2/3 transcription factor phosphorylation. In skeletal muscle cell cultures (such as C2C12 myoblasts), this inhibition reduces the transcription of genes responsible for muscle protein degradation, such as TRIM63 (MuRF1) and FBXO32 (Atrogin-1). Researchers analyzing pathways in the PX1 research library utilize Follistatin to delineate downstream signaling cascades involved in cellular hypertrophy and extracellular matrix modeling.
In vitro data indicate that neutralising Activin and Myostatin via Follistatin administration leads to accelerated myoblast proliferation and fusion into multinucleated myotubes. Rodent models expressing transgenic Follistatin or receiving recombinant protein administration display significant increases in total skeletal muscle mass and cross-sectional myofiber area without concomitant cardiac enlargement.
Beyond skeletal muscle, animal study data show that Follistatin signaling modulates fibrotic pathways across various organ systems, including hepatic, renal, and pulmonary tissues. Activin A acts as a pro-fibrotic mediator by stimulating fibroblast differentiation into active myofibroblasts; by sequestrating excess Activin A, Follistatin reduces collagen deposition and extracellular matrix accumulation in chronic inflammatory models.
When purchasing reagents from a follistatin peptid store, verifying analytical data is critical to preventing experimental artifact or cell culture toxicity. PX1 Research implements a multi-tiered testing regimen executed by an ISO 17025 accredited testing laboratory to ensure every batch meets rigid purity criteria:
1. Reverse-Phase HPLC (RP-HPLC): Measures chemical purity by separating main peptide peaks from truncated fragments or synthesis side-products. PX1 guarantees a minimum of 98% purity for all research peptides. 2. Electrospray Ionization Mass Spectrometry (ESI-MS): Confirms exact molecular mass, verifying sequence fidelity and missing residue checks. 3. Endotoxin Testing (LAL Assay): Essential for cell line viability and animal models, ensuring lipopolysaccharide (LPS) levels remain below strict threshold limits (<0.01 EU/µg).
Every product shipment includes a batch-specific Certificate of Analysis (COA) directly downloadable via lot number, establishing complete supply chain traceability for institutional procurement.
Laboratory researchers evaluating muscle biology pathways often compare Follistatin to alternative regulatory peptides in the same superfamily cluster. Understanding the operational differences between these molecules allows for precise model selection:
While Follistatin acts as a broad-spectrum scavenger neutralizing Activin A, Activin B, and Myostatin simultaneously, the myostatin propeptide research guide details a more targeted inhibitor that selectively binds GDF-8 without modulating Activin signaling. Conversely, compounds like IGF-1 LR3 stimulate myogenesis through an entirely distinct signaling axis—activating the PI3K/Akt/mTOR pathway rather than blocking TGF-β receptor activation. In tissue regeneration frameworks, researchers may also contrast these anabolic cascades with matrix-remodeling peptides such as the BPC-157 research peptide.
Proper reconstitution of lyophilized Follistatin is necessary to preserve tertiary protein structure and avoid aggregation. Standard reconstitution protocols in biochemical laboratories involve the following steps:
Allow the vial to equilibrate to room temperature before handling to prevent condensation on the lyophilized cake. Reconstitute using sterile bacteriostatic water, sterile normal saline (0.9% NaCl), or designated assay buffers depending on the downstream application. Gently introduce the diluent along the inner glass wall of the vial rather than shooting liquid directly onto the powder cake. Swirl gently in a circular motion—never vortex vigorously, as physical agitation can cause denaturation or shear stress in large protein structures.
For cell culture assays requiring low salt concentration, sterile phosphate-buffered saline (PBS, pH 7.4) may be utilized. If working with low concentrations (e.g., <0.1 mg/mL), adding 0.1% Bovine Serum Albumin (BSA) or Human Serum Albumin (HSA) as a carrier protein prevents non-specific binding to plastic microcentrifuge tubes and pipettes.
Follistatin is supplied as a lyophilized (freeze-dried) powder to maximize chemical stability during transit and storage. To ensure long-term stability in the laboratory setting, researchers should follow strict storage guidelines:
Unopened, lyophilized vials should be stored at -20°C or -80°C for long-term preservation (up to 24 months). Short-term storage of lyophilized powder at 2°C to 8°C is acceptable during active experimentation phases. Once reconstituted, liquid solutions should be aliquoted into single-use microcentrifuge tubes to prevent repeated freeze-thaw cycles, which degrade secondary and tertiary folding. Reconstituted aliquots stored at -20°C remain stable for several months, while refrigerated aliquots (4°C) should be utilized within 7 to 14 days.
Selecting PX1 Research as your verified follistatin peptid store provides scientific institutions with an operational standard tailored to rigorous laboratory requirements. All peptides are manufactured in the USA within state-of-the-art facilities compliant with Good Manufacturing Practices (GMP).
PX1 ships directly from dual logistics hubs in California and Arizona, ensuring rapid dispatch with same-day shipping on orders placed Monday through Friday before cut-off times. Whether managing single-assay protocols or sourcing bulk quantities via our wholesale and institutional accounts program, investigators benefit from guaranteed batch purity, full COA documentation, and reliable US-based fulfillment.
What is the primary function of Follistatin in laboratory research?
Follistatin acts as an autocrine protein that binds and inactivates TGF-β superfamily ligands, primarily Myostatin (GDF-8) and Activin A, suppressing downstream Smad2/3 signaling in cell culture and preclinical models.
How does PX1 Research verify the purity of Follistatin?
Every batch undergoes rigorous third-party analytical testing using RP-HPLC to confirm physical purity (>98%), mass spectrometry (ESI-MS) to confirm molecular weight, and LAL assays to quantify endotoxin levels.
What is the difference between Follistatin-344 and Follistatin-315?
Follistatin-344 includes a 29-amino-acid signal peptide sequence that is post-translationally cleaved in vivo to yield the circulating FST-315 isoform. Recombinant research formulations modeled on FST-344 are commonly used in vector and expression studies.
What diluent should be used for Follistatin reconstitution?
Depending on assay requirements, Follistatin is typically reconstituted using sterile bacteriostatic water, sterile 0.9% saline, or PBS (pH 7.4). Carrier proteins such as 0.1% BSA may be added for low-concentration solutions to prevent adsorption to plasticware.
What are the recommended long-term storage conditions for lyophilized Follistatin?
Lyophilized Follistatin should be stored at -20°C or -80°C in a dry environment protected from light. Under these conditions, the protein remains stable for up to 24 months.
Can reconstituted Follistatin undergo multiple freeze-thaw cycles?
No. Repeated freeze-thaw cycles cause structural degradation and protein aggregation. Reconstituted solutions should be divided into single-use aliquots before freezing.
Are Follistatin peptides supplied by PX1 Research suitable for human administration?
No. All products offered by PX1 Research are strictly designated for laboratory in vitro and preclinical research applications. They are not intended for human or veterinary use, medical treatment, or clinical diagnosis.
Where are PX1 Research products manufactured and shipped from?
All PX1 Research compounds are manufactured in domestic US facilities and shipped directly from fulfillment centers in California and Arizona, featuring same-day M-F dispatch.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.